Risk Factors of HCC After HBsAg Seroclearance Risk Factors of HCC After HBsAg Seroclearance
Which factors might increase risk of hepatocellular carcinoma among patients with chronic hepatitis B who have achieved seroclearance of hepatitis B surface antigen?Journal of Viral Hepatitis (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 9, 2018 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

J & J, Arrowhead partner on gene-silencing drug
Johnson& Johnson ’s Janssen Pharmaceuticals has entered into an agreement with Arrowhead Pharmaceuticals for an exclusive, worldwide license to develop and commercialize a therapy candidate being investigated for the treatment of chronic hepatitis B viral infection. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - October 4, 2018 Category: Pharmaceuticals Source Type: news

Janssen Announces Exclusive, Worldwide License Agreement with Arrowhead Pharmaceuticals to Develop and Commercialize a New Treatment for Chronic Hepatitis B Viral Infection
(Source: Johnson and Johnson)
Source: Johnson and Johnson - October 4, 2018 Category: Pharmaceuticals Source Type: news

J & J, Arrowhead in gene-silencing drug deal worth up to $3.7 billion
Arrowhead Pharmaceuticals Inc said on Thursday Johnson& Johnson would develop and market its gene-silencing Hepatitis B drug and pick up a minor stake in the company in a deal that could be potentially worth more than $3.7 billion. (Source: Reuters: Health)
Source: Reuters: Health - October 4, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Tenofovir Beats Entecavir for Preventing Liver Cancer? Tenofovir Beats Entecavir for Preventing Liver Cancer?
An observational study reports that in patients with hepatitis B, tenofovir significantly lowers the risk for liver cancer compared with entecavir.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 2, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Patrons of'Vampire Facial' Spa May Have Been Exposed to HIV
FRIDAY, Sept. 14, 2018 -- Customers of an Albuquerque spa who received a " vampire facial " are being warned that they may have been exposed to HIV, hepatitis B and hepatitis C through human blood used in the controversial procedure. In a vampire... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 14, 2018 Category: Pharmaceuticals Source Type: news

Gilead taps Durham gene editing firm for $445M deal
California biotech Gilead Sciences (Nasdaq: GILD) has teamed up with a Durham-based Precision BioSciences to develop therapies targeting hepatitis B – a deal that could be worth $445 million. At the center of the deal is Durham-based Precision BioSciences’ genome editing platform, dubbed ARCUS. On an earnings call, John McHutchison, Gilead’s chief scientific officer and head of research and development (and former Associate Director of t he Duke Clinical Research Institute in Durham), said… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 14, 2018 Category: Biotechnology Authors: Lauren K. Ohnesorge Source Type: news

Gilead taps Durham gene editing firm for $445M deal
California biotech Gilead Sciences (Nasdaq: GILD) has teamed up with a Durham-based Precision BioSciences to develop therapies targeting hepatitis B – a deal that could be worth $445 million. At the center of the deal is Durham-based Precision BioSciences’ genome editing platform, dubbed ARCUS. On an earnings call, John McHutchison, Gilead’s Chief Scientific Officer and head of research and development (and former Associate Director of t he Duke Clinical Research Institute in Durham), said… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - September 13, 2018 Category: American Health Authors: Lauren K. Ohnesorge Source Type: news

Hepatitis B Virus and Risk of Non-Hodgkin Lymphoma Hepatitis B Virus and Risk of Non-Hodgkin Lymphoma
Several prior studies have suggested that chronic HBV infection can increase the risk of non-Hodgkin's lymphoma. What's the current best evidence on this possible relationship?Journal of Viral Hepatitis (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 11, 2018 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Hepatitis B pathway resource leaflet
Public Health England has published guidance on hepatitis B including links to available resources. (Source: NHS Networks)
Source: NHS Networks - September 4, 2018 Category: UK Health Source Type: news

Requiring insurers to cover retail pharmacy vaccinations for adult Californians could save lives, study finds
Requiring health insurers to pay for adult vaccinations given at retail pharmacies could help prevent the spread of deadly communicable diseases such as influenza, pneumococcal infection and human papillomavirus, according to a  new study by the UCLA Center for Health Policy Research.Many insurers do not cover pharmacy-administered vaccines; cover a limited selection of vaccines; or require people they insure to get vaccinated only at pharmacies within their insurance network, the study reports.Overall vaccination rates in state are lowThe overall vaccination rate among adult Californians is far below federa...
Source: UCLA Newsroom: Health Sciences - August 30, 2018 Category: Universities & Medical Training Source Type: news

Factors Impacting Diabetes Risk in HIV-infected Patients Factors Impacting Diabetes Risk in HIV-infected Patients
Is there an association between chronic hepatitis C and incidence of diabetes mellitus? What role might factors such as cirrhosis, duration of infection, and chronic hepatitis B infection play?Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 30, 2018 Category: Consumer Health News Tags: HIV/AIDS Journal Article Source Type: news

Acute Hepatitis B (England): annual reports
This annual report gives the statistics for acute hepatitis B in England. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - August 29, 2018 Category: Consumer Health News Source Type: news

Hepatitis B (HBV, Hep B)
Title: Hepatitis B (HBV, Hep B)Category: Diseases and ConditionsCreated: 1/26/2001 12:00:00 AMLast Editorial Review: 8/14/2018 12:00:00 AM (Source: MedicineNet Digestion General)
Source: MedicineNet Digestion General - August 14, 2018 Category: Nutrition Source Type: news

Flu, Tdap, Shingles and More: A List of Vaccines for Age 50+
Every Vaccine You Need After Age 50 ... There are three vaccines every adult needs — Influenza, Tdap, and Shingles. Two others, Hepatitis A and Hepatitis B — are needed for certain risk factors. ..... (Source: AARP.org News)
Source: AARP.org News - August 13, 2018 Category: American Health Source Type: news

Uganda:Why Uganda War Against Hepatitis B Is Not Won Yet
[East African] Although Uganda has undertaken a mass vaccination campaign since 2015 against Hepatitis B, the prevalence of the disease in the country remains at a high 4.3 per cent. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - August 10, 2018 Category: African Health Source Type: news

Uganda:Hepatitis B Vaccine Runs Out, More Than 1,000 At Risk
[Monitor] More than 1,000 people are reportedly at risk of missing the second immunisation cycle against Hepatitis B due to stock-outs at Bupandengo Health Centre III in Nawanyago Sub-county, Kamuli District. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - August 8, 2018 Category: African Health Source Type: news

Scientists shed new light on hepatitis B virus origins
(eLife) Researchers have provided new insight on the geographical origins and global spread of two classes of the hepatitis B virus (HBV), according to a study in eLife. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 7, 2018 Category: International Medicine & Public Health Source Type: news

Tanzania:Hepatitis B, C Incidence Rising - Medical Officer
[Daily News] Dodoma -At least 85 people out of 2,885, who donated blood at Dodoma Regional Blood Bank Centre in June this year, were found with Hepatitis B and 27 people with Hepatitis C. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - August 2, 2018 Category: African Health Source Type: news

Pediarix (Diphtheria, Tetanus Toxoids and Acellular Pertussis Adsorbed, Hepatitis B and Inactivated Poliovirus Vaccine) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - August 1, 2018 Category: Drugs & Pharmacology Source Type: news

NFID Initiative Working to Up Hepatitis B Vaccination Rates
FRIDAY, July 27, 2018 -- A new initiative to increase hepatitis B virus vaccination rates among at-risk adults has been developed, according to a report from the National Foundation for Infectious Diseases (NFID) published in support of World... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 27, 2018 Category: Pharmaceuticals Source Type: news

Heplisav B (Hepatitis B Vaccine Solution for Intramuscular Injection) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - July 27, 2018 Category: Drugs & Pharmacology Source Type: news

Nigeria:WHO Seeks Urgent Increase in Hepatitis Testing, Treatment
[Guardian] Ahead of the World Hepatitis Day (WHD) in July 28, the World Health Organisation (WHO) and partners have called for urgent increase in testing and treatment services to reduce 1.34 million lives lost to hepatitis B and C. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - July 27, 2018 Category: African Health Source Type: news

WHO Targets for Chronic Hepatitis B Will Be Cost-Effective
THURSDAY, July 26, 2018 -- Meeting World Health Organization (WHO) targets for chronic hepatitis B by 2030 will be cost-effective, according to a report published in the July issue of Health Affairs. Mehlika Toy, Ph.D., from the Stanford University... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 26, 2018 Category: Pharmaceuticals Source Type: news

Genetic variation may increase risk of liver damage in patients with chronic hepatitis B
(Westmead Institute for Medical Research) A new study has shown that genetic variation may increase the risk of severe liver damage in Caucasians with chronic hepatitis B infection. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 26, 2018 Category: International Medicine & Public Health Source Type: news

Availability of Generic Antivirals for Hepatitis B Increasing
FRIDAY, July 20, 2018 -- Availability of generic antivirals for treating chronic hepatitis B virus (HBV) is increasing, according to research published in the July 20 issue of the U.S. Centers for Disease Control and Prevention's Morbidity and... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 20, 2018 Category: Pharmaceuticals Source Type: news

Access to Treatment for Hepatitis B Virus Infection - Worldwide, 2016
Among persons living with HBV worldwide, approximately 27 million (10.5%) were aware of their infection, including 4.5 million (16.7%) who were on treatment. In 2017, all but two low- and middle-income countries could legally procure generic entecavir or tenofovir, the medicines active against HBV infection. (Source: PHPartners.org)
Source: PHPartners.org - July 19, 2018 Category: International Medicine & Public Health Source Type: news

Liver Cancer Death Rate In US Surged 43% In 16 Years
(CNN) — Death rates from liver cancer increased 43% for American adults from 2000 to 2016, according to a report released Tuesday by the US Centers for Disease Control and Prevention’s National Center for Health Statistics. The increase comes even as mortality for all cancers combined has declined. Liver cancer death rates increased for both men and women 25 and older, as well as white, black and Hispanic people. Only Asians and Pacific Islanders saw a decrease in mortality from liver cancer. The rise in mortality doesn’t mean that liver cancer is deadlier than before, according to Dr. Jiaquan Xu, the aut...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - July 17, 2018 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health News Cancer Liver Cancer Source Type: news

Uganda:Government to Offer Free Cancer Screening Services At Fitness Day Launch
[Monitor] Government will Sunday offer free screening services for cancer, diabetes, yellow fever, hepatitis B and heart related diseases as President Museveni launches the National Physical Activity Day at Kololo grounds. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - July 11, 2018 Category: African Health Source Type: news

What is the Interval For Non-simultaneous Administration of Live Virus Vaccines?
Discussion Vaccines are a mainstay of infectious disease prevention and health promotion. Infants, children and adults benefit from vaccines the most when they are given on the recommended schedules. However there are times when this is not possible as children come to the physician a little early, or a little late, or had unavailable records and so received addition vaccine, etc. There are many questions that arise because of these timing issues such as the one above. Standard vaccine schedules can be reviewed here. Commonly administered vaccines includes: Live-attenuated vaccines Cholera Measles, mumps, rubella (MMR ...
Source: PediatricEducation.org - July 9, 2018 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

Africa:Simple Blood Test Offers Hope to Hepatitis Patients
[CAJ News] Banjul -A blood test worth $20 could be the universal remedy to diagnose thousands of patients with hepatitis B and in need of treatment in some of Africa's poorest regions. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - July 2, 2018 Category: African Health Source Type: news

$20 blood test could help diagnose hepatitis B patients across Africa
(Imperial College London) A simple $20 blood test could help diagnose thousands of patients with hepatitis B in need of treatment in some of Africa's poorest regions. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 1, 2018 Category: International Medicine & Public Health Source Type: news

A flavonoid in fruits and vegetables found to prevent hepatitis B
(Natural News) Naringenin is a dietary flavonoid present in many fruits, herbs, and vegetables. Taiwanese researchers believe this phytochemical can stop the hepatitis B virus (HBV) from causing hepatitis, liver cirrhosis, and liver cancer. The virus spreads by infecting the host DNA with the HBV X protein (HBx). Even as the liver heals following every instance of... (Source: NaturalNews.com)
Source: NaturalNews.com - June 29, 2018 Category: Consumer Health News Source Type: news

National Hepatitis B & C Training Program and Treatment 2018-San Diego
July 28, 2018; La Jolla, CA.(Scripps) (Source: PHPartners.org)
Source: PHPartners.org - June 28, 2018 Category: International Medicine & Public Health Source Type: news

U.S. government statistics reveal that the flu vaccine is the most dangerous vaccine in America
(Natural News) Even the bestselling flu vaccine is only the fifth most popular vaccine in the United States. Prevnar, the vaccine used to prevent infection caused by pneumococcal bacteria; Gardasil, which supposedly prevents cervical cancer; PENTAct-HIB, given to tiny infants to stave off diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis, and Haemophilus influenzae type b; and... (Source: NaturalNews.com)
Source: NaturalNews.com - June 22, 2018 Category: Consumer Health News Source Type: news

Digital health news briefs: STD testing at home, VR distraction therapy
Finding time to get tested. Patients may now be able to address sexual healthcare issues through video conferencing. KnowNow Health has just launched a new website called App:KnowNOWSTD.com. The platform offers online lab testing for STDs including HIV, Gonorrhea, Chlamydia, Syphilis, Hepatitis C and Hepatitis B. The platform will also be able to offer care for women health conditions including urinary tract infections, bacterial vaginosis and yeast infections. (Source: mobihealthnews)
Source: mobihealthnews - June 21, 2018 Category: Information Technology Source Type: news

Liver Cancer Doubled in High-Income Countries Liver Cancer Doubled in High-Income Countries
Rates of liver cancer have doubled since the 1990s in high-income countries and are largely due to infection with hepatitis B and C, as well as nonalcoholic fatty liver disease.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 18, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Call for all children to receive hepatitis B vaccination at birth
All children around the world should receive the hepatitis B vaccination at birth, as recommended by the World Health Organization (WHO), according to a global expert on the disease. (Source: Nursing Times)
Source: Nursing Times - June 15, 2018 Category: Nursing Source Type: news

Hepatitis B and the Opioid Crisis
June 19, 2018 3:00-4:00pm ET. (Source: PHPartners.org)
Source: PHPartners.org - June 7, 2018 Category: International Medicine & Public Health Source Type: news

Nabi-HB (Hepatitis B Vaccine Recombinant) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - June 7, 2018 Category: Drugs & Pharmacology Source Type: news

HepaGam B (Hepatitis B Immune Globulin (Human)) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - June 6, 2018 Category: Drugs & Pharmacology Source Type: news

Improving Linkage to Care Among Non-US Born Persons With HBV Improving Linkage to Care Among Non-US Born Persons With HBV
Seventy percent of persons in the US with chronic hepatitis B virus are non-US born. How well are we doing with providing hepatitis B testing and linkage-to-care programs to this population?Morbidity & Mortality Weekly Report (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 5, 2018 Category: Consumer Health News Tags: Infectious Diseases Journal Article Source Type: news

Hepatitis B Update: Vaccination and Follow-up Hepatitis B Update: Vaccination and Follow-up
CDC outlines the indications for hepatitis B vaccination, including the number of doses, postvaccination serology, and when revaccination is needed.CDC Expert Commentary (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 4, 2018 Category: Consumer Health News Tags: Infectious Diseases Commentary Source Type: news

Findings could lead to treatment of hepatitis B
(University of Delaware) Researchers have gained new insights into the virus that causes hepatitis B -- a life-threatening and incurable infection that afflicts more than 250 million people worldwide. The discovery reveals previously unknown details about the protein shell that encloses the virus' genetic blueprint and could lead to new drugs to treat the infection. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 4, 2018 Category: Infectious Diseases Source Type: news

ECDC and EMCDDA make the case for active case finding of communicable diseases in prison
(European Centre for Disease Prevention and Control (ECDC)) What are the most (cost-) effective ways to prevent and control communicable diseases in prison settings? In their Guidance ECDC and the European Monitoring Centre for Drugs and Drug Addiction, present the evidence on active case finding as key measure to diagnose communicable diseases early. The two agencies advise to actively offer testing for hepatitis B and C and HIV to all people in prison and to conduct universal testing for tuberculosis at prison entry. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - May 23, 2018 Category: Infectious Diseases Source Type: news

Tanzania:Dispensaries in Tanzania to Have Hepatitis Rapid Tests, Minister Says
[Citizen] Dodoma -Deputy health minister Dr Faustine Ndugulile said on Thursday that the government was considering to spread rapid testing of hepatitis B (HBV) which he said its infection was leading among other types in Tanzania. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - May 18, 2018 Category: African Health Source Type: news

U.S. - North Korea Meeting Could Be Make Or Break For Global Health Security
Recently, small amounts of info about North Korea's health system have made their way out of the country. Data points have gone from bad to worse to accusations of massive human rights violations. Malnutrition, tuberculosis, malaria and hepatitis B, are a health security nightmare waiting to happen. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - May 18, 2018 Category: Pharmaceuticals Authors: Nicole Fisher, Contributor Source Type: news

Infectious Diseases and the Opioid Epidemic
National Association of County and City Health Officials. 01/2018 This Web page provides resources for health departments about the opioid epidemic and the increased the risk of transmission of blood-borne viruses, including HIV, hepatitis C virus (HCV), and hepatitis B virus (HBV) through unsafe injection practices. The resources will help health departments assess local vulnerability to the spread of hepatitis and HIV among people who inject drugs, and determine what actions are needed to prepare for and respond to this vulnerability. (Text) (Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - May 18, 2018 Category: International Medicine & Public Health Authors: The U.S. National Library of Medicine Source Type: news

Community-Based Services to Improve Testing and Linkage to Care Among Non –U.S.-Born Persons with Chronic Hepatitis B Virus Infection — Three U.S. Programs, October 2014–September 2017
(Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - May 17, 2018 Category: American Health Source Type: news

Community-Based Services to Improve Testing and Linkage to Care Among Non-U.S.-Born Persons with Chronic Hepatitis B Virus Infection - Three U.S. Programs, October 2014-September 2017
CDC funded three programs to develop hepatitis B testing and linkage-to-care programs serving non-U.S.-born persons during 2014-2017; 78% of persons with chronic HBV infection were linked to care using community-based services. HBV infection rate among household contacts of HBsAg-positive persons was 14%. (Source: PHPartners.org)
Source: PHPartners.org - May 17, 2018 Category: International Medicine & Public Health Source Type: news